Sequana Medical Investor Presentation 2021 - Fluid Overload Treatment

Sequana Medical presents innovative treatment solutions for diuretic-resistant fluid overload conditions including liver disease-related malignant ascites and heart failure. The presentation covers the company's alfapump® system and DSR® therapy pipeline, with regulatory updates on ongoing clinical investigations in multiple markets.